Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Watanabe

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Anticancer Research|July 26, 2024
Preoperative Visceral-to-Subcutaneous Fat Ratio by Sex as a Predictor of Postoperative Survival in Patients With Gastric CancerItaru Hashimoto, Keisuke Komori, Shizune Onuma, et al.
Anticancer Research|February 27, 2022
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With NivolumabHideaki Suematsu, Kazuki Kano, Takanobu Yamada, et al.
Anticancer Research|April 4, 2021
Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal CancerTakuo Watanabe, Manabu Shiozawa, Yayoi Kimura, et al.
In Vivo (Athens, Greece)|January 6, 2021
Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab MonotherapyHayato Watanabe, Takanobu Yamada, Keisuke Komori, et al.
Annals of Surgical Oncology|May 20, 2020
Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric CancerKazuki Kano, Takanobu Yamada, Kouji Yamamoto, et al.
Anticancer Research|March 6, 2020
Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1Hayato Watanabe, Tsutomu Hayashi, Keisuke Komori, et al.
Anticancer Research|September 3, 2021
Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal CancerShinsuke Nagasawa, Kazuhito Tsuchida, Manabu Shiozawa, et al.
In Vivo (Athens, Greece)|August 19, 2021
Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric CancerKenki Segami, Toru Aoyama, Yukihiko Hiroshima, et al.
Anticancer Research|July 7, 2021
Clinical Significance of <i>PLA2G2A</i> Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1Shinsuke Hatori, Kentaro Sakamaki, Takehiko Yokohori, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Anticancer Research|July 26, 2024
Preoperative Visceral-to-Subcutaneous Fat Ratio by Sex as a Predictor of Postoperative Survival in Patients With Gastric CancerItaru Hashimoto, Keisuke Komori, Shizune Onuma, et al.
Anticancer Research|February 27, 2022
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With NivolumabHideaki Suematsu, Kazuki Kano, Takanobu Yamada, et al.
Anticancer Research|April 4, 2021
Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal CancerTakuo Watanabe, Manabu Shiozawa, Yayoi Kimura, et al.
In Vivo (Athens, Greece)|January 6, 2021
Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab MonotherapyHayato Watanabe, Takanobu Yamada, Keisuke Komori, et al.
Annals of Surgical Oncology|May 20, 2020
Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric CancerKazuki Kano, Takanobu Yamada, Kouji Yamamoto, et al.
Anticancer Research|March 6, 2020
Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1Hayato Watanabe, Tsutomu Hayashi, Keisuke Komori, et al.
Anticancer Research|September 3, 2021
Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal CancerShinsuke Nagasawa, Kazuhito Tsuchida, Manabu Shiozawa, et al.
In Vivo (Athens, Greece)|August 19, 2021
Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric CancerKenki Segami, Toru Aoyama, Yukihiko Hiroshima, et al.
Anticancer Research|July 7, 2021
Clinical Significance of <i>PLA2G2A</i> Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1Shinsuke Hatori, Kentaro Sakamaki, Takehiko Yokohori, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Pageof 8